The design, synthesis and biological actions of a novel, non-peptide CCK1 r
eceptor agonist (PD 170292) which exhibits a similar pharmacological profil
e to the CCK analogue JMV180 is reported. PD 170292 was designed based on a
consideration of the structures of a peptide based CCK1 receptor selective
agonist and a peptoid CCK2 receptor selective antagonist. (C) 2000 Elsevie
r Science Ltd. All rights reserved.